CML is consistently associated with fusion by chromosome translocation of the breakpoint cluster region gene (BCR) at chromosome 22q11 to the Abelson gene (ABL1) at chromosome 9q34. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.